China’s Biotech Moment Outpaces AI, Igniting Global Investor Interest
China’s biotechnology sector is experiencing an explosive resurgence, with its performance this year surpassing even the much-hyped artificial intelligence wave. After years of subdued investor interest, the sector is seeing a dramatic reversal, driven by landmark licensing deals, blockbuster IPOs, and growing global recognition of China’s research capabilities. Since the beginning of 2025, the Hang […]
China’s Biotech Moment Outpaces AI, Igniting Global Investor Interest Read More »